SUBOXONE (Buprenorphine And Naloxone) Film, Soluble [Reckitt Benckiser Pharmaceuticals Inc.]

July 1, 2012

Updated Date: Sep 20, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Read the full article →

Suboxone (Buprenorphine HCl and naloxone HCl) – updated on RxList

July 1, 2012

Suboxone (Buprenorphine HCl and naloxone HCl) drug description – FDA approved labeling for prescription drugs and medications at RxList (Source: RxList – New and Updated Drug Monographs) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Read the full article →

Buprenorphine Implants for Treatment of Opioid Dependence: A Randomized Controlled Trial [Original Contribution]

July 1, 2012

Conclusion  Among persons with opioid dependence, the use of buprenorphine implants compared with placebo resulted in less opioid use over 16 weeks as assessed by urine samples. Trial Registration  clinicaltrials.gov Identifier: NCT00447564 (Source: JAMA)

Read the full article →

Implantable Agent Cuts Positive Urine Screens (CME/CE)

July 1, 2012

(MedPage Today) — An implantable form of the opioid addiction drug buprenorphine (Subutex, Suboxone) kept more patients testing “clean” for four months compared with placebo, researchers reported. (Source: MedPage Today Psychiatry)

Read the full article →

Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.

July 1, 2012

Authors: Maremmani I, Gerra G Maintenance therapy with methadone or buprenorphine-based regimens reduces opioid dependence and associated harms. The perception that methadone is more effective than buprenorphine for maintenance treatment has been based on low buprenorphine doses and excessively slow induction regimens used in early buprenorphine trials. Subsequent studies show that the efficacy of buprenorphine […]

Read the full article →

The Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Patients with Chronic, Non-Malignant Pain who are Maintained on Sublingual Buprenorphine/Naloxone

July 1, 2012

The Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Patients with Chronic, Non-Malignant Pain who are Maintained on Sublingual Buprenorphine/Naloxone Neuropsychopharmacology advance online publication, October 27, 2010. doi:10.1038/npp.2010.172 Authors: Jermaine D Jones, Maria A Sullivan, Jeanne Manubay, Suzanne K Vosburg & Sandra D Comer Keywords: opioids; pain/analgesics; addiction & substance abuse; psychopharmacology; buprenorphine (Source: Neuropsychopharmacology)

Read the full article →

Accidental and Non-Accidental Ingestion of Methadone and Buprenorphine in Childhood: A Single Center Experience, 1999-2009.

July 1, 2012

Conclusions: Accidental and non-accidental ingestion of methadone and buprenorphine by children is increasing in proportion to increased clinical use and availability. Health providers should be aware of this increased risk and be able to provide appropriate treatment and family support. PMID: 21047302 [PubMed – as supplied by publisher] (Source: Current Drug Safety) MedWorm Sponsor Message: […]

Read the full article →

N.Y. to Prescribe Suboxone for Ex-Prisoners

July 1, 2012

The state of New York plans to give some state prisoners the opiate-treatment drug Suboxone to help them stay off heroin upon release. (Source: Alcohol, Tobacco and Other Drugs News)

Read the full article →

The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia

July 1, 2012

Conclusions: Our data indicates that the inhalation of buprenorphine has occurred in a significant minority of Australian OST clients. The motivations, contexts and potential health consequences of buprenorphine use by these atypical routes of administration, particularly in a correctional setting, warrant further exploration. (Source: International Journal of Drug Policy)

Read the full article →

Sublingual Buprenorphine

July 1, 2012

OPIOID-DEPENDENT PATIENTS present a unique perioperative care challenge. These patients are managed as outpatients in several different manners. The type of treatment that such patients receive can have a profound impact on their perioperative care when they present for surgery. One management option is the use of sublingual (SL) buprenorphine to treat opioid dependence. This […]

Read the full article →